These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24896098)

  • 1. Early treatment with anti-VLA-4 mAb can prevent the infiltration and/or development of pathogenic CD11b+CD4+ T cells in the CNS during progressive EAE.
    Mindur JE; Ito N; Dhib-Jalbut S; Ito K
    PLoS One; 2014; 9(6):e99068. PubMed ID: 24896098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tellurium compound AS101 ameliorates experimental autoimmune encephalomyelitis by VLA-4 inhibition and suppression of monocyte and T cell infiltration into the CNS.
    Lee JH; Halperin-Sheinfeld M; Baatar D; Mughal MR; Tae HJ; Kim JW; Carter A; Lustig A; Snir O; Lavie G; Okun E; Mattson MP; Sredni B; Taub DD
    Neuromolecular Med; 2014 Jun; 16(2):292-307. PubMed ID: 24272426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage brain infiltration in experimental autoimmune encephalomyelitis is not completely compromised by suppressed T-cell invasion: in vivo magnetic resonance imaging illustration in effective anti-VLA-4 antibody treatment.
    Deloire MS; Touil T; Brochet B; Dousset V; Caillé JM; Petry KG
    Mult Scler; 2004 Oct; 10(5):540-8. PubMed ID: 15471371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody to α4 integrin suppresses natural killer cells infiltration in central nervous system in experimental autoimmune encephalomyelitis.
    Gan Y; Liu R; Wu W; Bomprezzi R; Shi FD
    J Neuroimmunol; 2012 Jun; 247(1-2):9-15. PubMed ID: 22503411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis.
    Matejuk A; Bakke AC; Hopke C; Dwyer J; Vandenbark AA; Offner H
    J Neurosci Res; 2004 Jul; 77(1):119-26. PubMed ID: 15197745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of endogenous activated protein C attenuates experimental autoimmune encephalomyelitis by inducing myeloid-derived suppressor cells.
    Alabanza LM; Esmon NL; Esmon CT; Bynoe MS
    J Immunol; 2013 Oct; 191(7):3764-77. PubMed ID: 23997223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adhesion Molecule Profile and the Effect of Anti-VLA-4 mAb Treatment in Experimental Autoimmune Encephalomyelitis, a Mouse Model of Multiple Sclerosis.
    Pyka-Fościak G; Lis GJ; Litwin JA
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CD48 Monoclonal Antibody Attenuates Experimental Autoimmune Encephalomyelitis by Limiting the Number of Pathogenic CD4+ T Cells.
    McArdel SL; Brown DR; Sobel RA; Sharpe AH
    J Immunol; 2016 Oct; 197(8):3038-3048. PubMed ID: 27581174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis.
    Theien BE; Vanderlugt CL; Eagar TN; Nickerson-Nutter C; Nazareno R; Kuchroo VK; Miller SD
    J Clin Invest; 2001 Apr; 107(8):995-1006. PubMed ID: 11306603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of experimental autoimmune encephalomyelitis by VLA-2 blockade.
    Tsunoda I; Terry EJ; Marble BJ; Lazarides E; Woods C; Fujinami RS
    Brain Pathol; 2007 Jan; 17(1):45-55. PubMed ID: 17493037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of treatment with a small-molecule VLA-4 antagonist before and after onset of relapsing EAE.
    Theien BE; Vanderlugt CL; Nickerson-Nutter C; Cornebise M; Scott DM; Perper SJ; Whalley ET; Miller SD
    Blood; 2003 Dec; 102(13):4464-71. PubMed ID: 12933585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defects in CD4+ T cell LFA-1 integrin-dependent adhesion and proliferation protect Cd47-/- mice from EAE.
    Azcutia V; Bassil R; Herter JM; Engelbertsen D; Newton G; Autio A; Mayadas T; Lichtman AH; Khoury SJ; Parkos CA; Elyaman W; Luscinskas FW
    J Leukoc Biol; 2017 Feb; 101(2):493-505. PubMed ID: 27965383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DAB389IL-2 suppresses autoimmune inflammation in the CNS and inhibits T cell-mediated lysis of glial target cells.
    Bhopale MK; Hilliard B; Constantinescu CS; Fujioka T; Ventura E; Phillips SM; Rostami A
    Exp Mol Pathol; 2014 Feb; 96(1):108-17. PubMed ID: 23872438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of MCAM/CD146 impedes CNS infiltration of T cells over the choroid plexus.
    Breuer J; Korpos E; Hannocks MJ; Schneider-Hohendorf T; Song J; Zondler L; Herich S; Flanagan K; Korn T; Zarbock A; Kuhlmann T; Sorokin L; Wiendl H; Schwab N
    J Neuroinflammation; 2018 Aug; 15(1):236. PubMed ID: 30134924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
    Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
    Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate IFN-γ promotes development of experimental autoimmune encephalomyelitis: a role for NK cells and M1 macrophages.
    Dungan LS; McGuinness NC; Boon L; Lynch MA; Mills KH
    Eur J Immunol; 2014 Oct; 44(10):2903-17. PubMed ID: 25056715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
    Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
    Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
    Rostami A; Ciric B
    J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC; Lalor SJ; Lynch MA; Mills KH
    Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment.
    Brocke S; Piercy C; Steinman L; Weissman IL; Veromaa T
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6896-901. PubMed ID: 10359810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.